Literature DB >> 9097922

Production of interleukins 10 and 12 by peripheral blood mononuclear cells (PBMC) in chronic hepatitis C virus (HCV) infection.

S Kakumu1, A Okumura, T Ishikawa, K Iwata, M Yano, K Yoshioka.   

Abstract

We previously reported that interferon-gamma (IFN-gamma) production by PBMC in response to HCV core protein was increased in patients with type C chronic liver disease. To understand better the pathophysiology of this disease, we evaluated production of IL-10 and IL-12 by PBMC from 41 patients with chronic HCV infection, including asymptomatic HCV carriers with persistently normal serum ALT values. IL-10 is known to inhibit many effector functions of the immune system, suppressing Th1-type cell development, while IL-12 stimulates differentiation of Th1-type cells, facilitating cell-mediated immunity. IL-10 production was determined by culturing lymphocytes with concanavalin A (Con A), while IL-12 was produced by monocytes in the presence of Staphylococcus aureus Cowan 1 (SAC) with or without recombinant HCV core protein, respectively. The cytokine levels in culture supernatants were measured by ELISA. Spontaneous IL-10 production was greater in patients with chronic hepatitis (CH) (229 +/- 119 pg/ml, P < 0.01) and liver cirrhosis (LC) (185 +/- 88 pg/ml, P < 0.05) than in controls (119 +/- 27 pg/ml), while it was decreased during IFN treatment (70 +/- 25 pg/ml). Both HCV core protein and Con A enhanced IL-10 production by cells from HCV-infected patients. IL-12 was not detectable in medium alone cultures, and SAC-induced IL-12 production did not differ between various patient groups and controls. Simultaneous addition of HCV protein resulted in an increase of IL-12 production in chronic liver disease compared with SAC-alone cultures. Addition of IL-10 to the cultures equally suppressed IFN-gamma production for both controls and patient groups, but the enhancing effect of IL-12 on IFN-gamma production was significantly less in LC than in controls and other patient groups. The findings suggest that secretion of IL-10/IL-12 by cells from control individuals and various patient groups may be different, and that the cytokines might show different effects on IFN-gamma production by some cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9097922      PMCID: PMC1904630          DOI: 10.1046/j.1365-2249.1997.d01-987.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin.

Authors:  F Torre; S Rossol; N Pelli; M Basso; A Delfino; A Picciotto
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

2.  Influence of costimulatory molecules on immune response to Leishmania major by human cells in vitro.

Authors:  C I Brodskyn; G K DeKrey; R G Titus
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

3.  Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users.

Authors:  J K Flynn; G J Dore; M Hellard; B Yeung; W D Rawlinson; P A White; J M Kaldor; A R Lloyd; R A Ffrench
Journal:  J Viral Hepat       Date:  2010-07-05       Impact factor: 3.728

4.  Pro-inflammatory cytokine release and mediation of the acute phase protein response in fulminant hepatic failure.

Authors:  S J Wigmore; T S Walsh; A Lee; J A Ross
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

5.  Relationship between interferon-gamma, interleukin-10, and interleukin-12 production in chronic hepatitis C and in vitro effects of interferon-alpha.

Authors:  G Piazzolla; C Tortorella; O Schiraldi; S Antonaci
Journal:  J Clin Immunol       Date:  2000-01       Impact factor: 8.317

6.  HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C.

Authors:  Rainer P Woitas; Uwe Petersen; Dirk Moshage; Hans H Brackmann; Bertfried Matz; Tilman Sauerbruch; Ulrich Spengler
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

7.  Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virus.

Authors:  Marie Larsson; Ethan Babcock; Arash Grakoui; Naglaa Shoukry; Georg Lauer; Charles Rice; Christopher Walker; Nina Bhardwaj
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

8.  Postnatal persistent infection with classical Swine Fever virus and its immunological implications.

Authors:  Sara Muñoz-González; Nicolas Ruggli; Rosa Rosell; Lester Josué Pérez; Maria Teresa Frías-Leuporeau; Lorenzo Fraile; Maria Montoya; Lorena Cordoba; Mariano Domingo; Felix Ehrensperger; Artur Summerfield; Llilianne Ganges
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

9.  The anti-idiotypic antibody 1F7 stimulates monocyte interleukin-10 production and induces endotoxin tolerance.

Authors:  Tigran K Davtyan; David A Poghosyan; Anna G Sukiasyan; Michael D Grant
Journal:  J Inflamm (Lond)       Date:  2013-04-05       Impact factor: 4.981

10.  CD4+ primary T cells expressing HCV-core protein upregulate Foxp3 and IL-10, suppressing CD4 and CD8 T cells.

Authors:  Cecilia Fernandez-Ponce; Margarita Dominguez-Villar; Enrique Aguado; Francisco Garcia-Cozar
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.